Moderna shares plunge after leak of partial cancer vaccine data

Moderna shares dropped as much as 25% on Thursday following the leak of partial data on its closely watched cancer vaccine developed with Merck. In this article MRNA

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。